bio rad platelia toxo igm assay Search Results


qualitative plateliatm toxo igm  (Bio-Rad)
93
Bio-Rad qualitative plateliatm toxo igm
*: PS = plasma sample. a : available plasma samples at inclusion, or during the first antenatal care visit or the next visit, not exceeding one month after the first one. b : diluted and undiluted plasma samples (see : “Methodological constraints”). c : poor quality plasma samples with too much cell debris. d : serological toxoplasmosis results positive <t>(Toxo</t> POS) or negative (Toxo NEG). e : available plasma samples corresponding to the end of the study, usually at delivery or during a previous visit not exceeding one month before delivery. **: CT = congenital toxoplasmosis.
Qualitative Plateliatm Toxo Igm, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/qualitative plateliatm toxo igm/product/Bio-Rad
Average 93 stars, based on 1 article reviews
qualitative plateliatm toxo igm - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


*: PS = plasma sample. a : available plasma samples at inclusion, or during the first antenatal care visit or the next visit, not exceeding one month after the first one. b : diluted and undiluted plasma samples (see : “Methodological constraints”). c : poor quality plasma samples with too much cell debris. d : serological toxoplasmosis results positive (Toxo POS) or negative (Toxo NEG). e : available plasma samples corresponding to the end of the study, usually at delivery or during a previous visit not exceeding one month before delivery. **: CT = congenital toxoplasmosis.

Journal: PLoS ONE

Article Title: Retrospective study of toxoplasmosis prevalence in pregnant women in Benin and its relation with malaria

doi: 10.1371/journal.pone.0262018

Figure Lengend Snippet: *: PS = plasma sample. a : available plasma samples at inclusion, or during the first antenatal care visit or the next visit, not exceeding one month after the first one. b : diluted and undiluted plasma samples (see : “Methodological constraints”). c : poor quality plasma samples with too much cell debris. d : serological toxoplasmosis results positive (Toxo POS) or negative (Toxo NEG). e : available plasma samples corresponding to the end of the study, usually at delivery or during a previous visit not exceeding one month before delivery. **: CT = congenital toxoplasmosis.

Article Snippet: Qualitative PlateliaTM TOXO IgM (Bio-Rad) detection assay was used on cord blood plasmas, according to the manufacturer’s recommendations.

Techniques: Clinical Proteomics